Extrawell Pharmaceutical Holdings Limited (HKG:0858)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0930
+0.0420 (82.35%)
Jun 24, 2025, 3:44 PM HKT
138.46%
Market Cap 121.89M
Revenue (ttm) 59.75M
Net Income (ttm) 175.71M
Shares Out 2.39B
EPS (ttm) 0.07
PE Ratio 0.78
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 273,560,000
Average Volume 1,459,500
Open 0.0580
Previous Close 0.0510
Day's Range 0.0580 - 0.0990
52-Week Range 0.0300 - 0.0930
Beta 0.07
RSI 51.88
Earnings Date Jun 27, 2025

About HKG:0858

Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People’s Republic of China and Hong Kong. It operates through Manufacturing, Trading, and Gene Development segments. The company manufactures transfer factor oral solution, a dual immune regulator for the treatment of diseases caused by virus infection and weak cellular immune system; Wisk for the treatment of II-III degree of radio-injury of skin, normal common burn, actinic dermatitis... [Read more]

Sector Healthcare
Founded 1998
Employees 159
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0858
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.